Analyst Ratings for Myriad Genetics (MYGN)

MYGN Rating Summary

MYGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MYGN
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $36.09 (+5.3%) * Over Last 12-Mos
Rating Score: 2.7 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/26/2015 Goldman Sachs Downgrade Sell
(Neutral)
25.00
(31.00)
36.20 34.29 -5.28% Details
3/10/2015 UBS New Coverage Sell
(N/A)
34.00
(N/A)
34.92 34.29 -1.8% Details
Like MYGN Ratings? Also take a look at AZN, TSRO, ABBV, BMRN

MYGN Ratings News